The National Cancer Institute has entered into a memorandum of understanding with the American Association for Clinical Chemistry (AACC) to join forces on promoting and educating the clinical chemistry community in the area of proteomic standards and technology advances.
The University of Iowa's Developmental Studies Hybridoma Bank (DSHB) collects, stores, grows, and distributes all hybridomas and monoclonal antibodies from the Clinical Proteomic Technologies for Cancer programs. The DSHB was established to supply investigators with monoclonal antibodies useful for studies in developmental and cell biology, which may be ordered as tissue culture supernatants, ascites, or concentrate; selected hybridomas are also available as frozen or growing cells.
The DNASU Plasmid Repository of the Biodesign Institute at Arizona State University (DNASU) serves as central repository for plasmid clone collections and distribution. DNASU currently stores and distributes nearly 100,000 plasmids including over 35,000 human and mouse plasmids, full genome collections of numerous organisms, the protein expression plasmids from the Protein Structure Initiative Material Repository (PSI-MR), and both small and large collections from individual researchers.
The Center for Personalized Diagnostics of the Biodesign Institute at Arizona State University applies Nucleic Acid Programmable Protein Arrays (NAPPA) technology to hybridomas and monoclonal antibodies from the CPTC programs. They have taken the next step after the Human Genome Project by cloning all available human genes in a standard form that enables full-length, high throughput protein expression. By developing and applying new resources and technologies, this institute enables the study of proteins on a genome-wide scale using informatics and automation. The Institute has produced over fifteen thousand clones to date. Additionally this institution serves as a repository for CPTC plasmid clone collections and distribution.